Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03763838 · ClinicalTrials.gov registry record · NA
Acupressure for Fatigue in Ovarian Cancer Survivors
A NA study of Ovarian Cancer and Fatigue, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 171
- Enrollment target
- 1
- Study location
NCT03763838 is a NA study of Ovarian Cancer and Fatigue that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 171 participants, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03763838, a NA study of Ovarian Cancer and Fatigue, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if accupressure can help reduce the severity of fatigue experienced by ovarian cancer patients. Acupressure involves applying mild to moderate physical pressure by fingers, hand or a device to specific points on the skin to try to bring about a change in the body's functioning, in this case relief from chronic fatigue.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER Acupressure
- OTHER Sham acupressure
Study Locations (1)
Michigan
- University of Michigan Rogel Cancer Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2019-10-07 |
| Est. Completion | 2024-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03763838
The ClinicalTrials.gov registry entry for NCT03763838 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (77% lower). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.
NCT03763838 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03763838 about?
NCT03763838 is a clinical study titled "Acupressure for Fatigue in Ovarian Cancer Survivors". The purpose of this study is to see if accupressure can help reduce the severity of fatigue experienced by ovarian cancer patients. Acupressure involves applying mild to moderate physical pressure by fingers, hand or a device to specific points on the skin to try to bring about a change in the body'...
What is the current status of trial NCT03763838?
This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2019-10-07. Estimated completion is 2024-06-18.
What conditions does trial NCT03763838 study?
This clinical trial studies the following conditions: Ovarian Cancer, Fatigue.
What interventions are being tested in trial NCT03763838?
The interventions under investigation include: Standard of Care (OTHER), Acupressure (OTHER), Sham acupressure (OTHER).
Who is sponsoring clinical trial NCT03763838?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03763838 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
RECRUITING · NA
-
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
RECRUITING · NA
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.